Clinical Trial Update: Metformin Combined With Gemcitabine as Adjuvant Therapy for Pancreatic Cancer After Curative Resection [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating metformin plus gemcitabine as adjuvant therapy after curative resection for pancreatic adenocarcinoma (stages IA–IIB) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• Gemcitabine (Gemcitabine)
• metformin (metformin)

Snippet

Sponsor: Xian-Jun Yu | Conditions: Stage IA Pancreatic Adenocarcinoma, Stage IB Pancreatic Adenocarcinoma | Phase 2 | Status: COMPLETED